✦ LIBER ✦

Effect of Fibroblast Growth Factor NV1FGF on Amputation and Death: A Randomized Placebo-Controlled Trial of Gene Therapy in Critical Limb Ischemia

✍ Scribed by J. Belch; W.R. Hiatt; I. Baumgartner

Book ID: 116713350
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 64 KB
Volume: 54
Category: Article
ISSN: 1097-6809
DOI: 10.1016/j.jvs.2011.08.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of fibroblast growth factor NV1FG

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

✍ Jill Belch; William R Hiatt; Iris Baumgartner; I Vickie Driver; Sigrid Nikol; La 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 286 KB

Recombinant human anti–transforming grow

Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192

✍ Christopher P. Denton; Peter A. Merkel; Daniel E. Furst; Dinesh Khanna; Paul Eme 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective To evaluate CAT‐192, a recombinant human antibody that neutralizes transforming growth factor β1 (TGFβ1), in the treatment of early‐stage diffuse cutaneous systemic sclerosis (dcSSc). ## Methods Patients with SSc duration of <18 months were randomly assigned to the place